A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The objective of this post-market, prospective study is to evaluate the clinical acceptability, blood leakage, risk for blood exposure, need for digital compression, insertion success, and clinical utility of the ViaValve™ Safety IV Catheter compared to standard hospital PIVCs currently being used.

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT06233214` - The Effect of the Vein Imaging Device Used in Peripheral Intravenous Catheter Application on the Success of the Procedure in Patients Coming to the Pediatric Emergency Department	N/A

NCT number	NCT02119351
Study type	Interventional
Source	Smiths Medical, ASD, Inc.
Contact
Status	Completed
Phase	N/A
Start date	July 2013
Completion date	December 2013

A Study Evaluating the Clinical Performance of the ViaValve™ Safety IV Catheter — ViaValve-001

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms